With Dan Montano's $1 million dollar judgement, confirmed by the United States Federal Court, against CVBT/Venturis Therapeutics a debtors exam is likely to happen. Since this claim appears unable to be offset by Venturis Therapeutics/CardioVascular BioTherapeutics (CVBT) how would a debtors exam affect the future of the company?
Would the debtors exam result bring forth the true financials of CVBT/Venturis Therapeutics? If it were to bring forth the true financials of our company, would that result in the deterioration if not shutting down of CVBT/Venturis Therapeutics?
Will our shareholders meeting address this pressing issue or will it be postponed again?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.